Vuong Trieu Insider Profile

4 Followers
Vuong Trieu, CSO, Director at Sorrento Therapeutics, holds 116.20M shares in Oncotelic Therapeutics (Ticker: OTLC), holds 3.01M shares in Sorrento Therapeutics (Ticker: SRNE). Most recently, Vuong Trieu Bought ― shares of Oncotelic Therapeutics on Aug 27, 2024 for an estimated value of 10.00K.
tipranks
Vuong Trieu

Vuong Trieu
Sorrento Therapeutics (SRNE)
CSO, Director

Ranked #76,845 out of 99,335 Corporate Insiders

Profitable Transactions

45%
5 out of 11 Profitable Transactions

Average Return

-12.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
99.12%
0.88%
A breakdown of Vuong Trieu's holdings

Insider Roles

Oncotelic Therapeutics
(OTLC)
Chairman & CEO, Director, Ten Percent Owner
Sorrento Therapeutics
(SRNE)
CSO, Director
Roles that Vuong Trieu holds in companies

Most Profitable Insider Trade

Stock:
Oncotelic Therapeutics
(OTLC)
Rating:Informative Buy
Date:Mar 27, 2020 - Mar 27, 2021
Return:+42.00%
The most profitable trade made by Vuong Trieu

Vuong Trieu's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Sorrento Therapeutics
Sep 19, 2013
CSO, Director
Uninformative Buy
$30.07K
Oncotelic Therapeutics
Aug 27, 2024
Chairman & CEO, Director, Ten Percent Owner
Informative Buy
10.00K
$3.37M
List of latest transactions for each holding click on a transaction to see Vuong Trieu's performance on stock

Vuong Trieu insider profile FAQ

What is the percentage of profitable transactions made by Vuong Trieu?
The percentage of profitable transactions made by Vuong Trieu is 45%.
    What is the average return per transaction made by Vuong Trieu?
    The average return per transaction made by Vuong Trieu is -12.00%.
      What stocks does Vuong Trieu hold?
      Vuong Trieu holds: SRNE, OTLC stocks.
        What was Vuong Trieu’s latest transaction?
        Vuong Trieu latest transaction was an Informative Buy of $10.00K.
          What was Vuong Trieu's most profitable transaction?
          Vuong Trieu’s most profitable transaction was an Informative Buy of OTLC stock on March 27, 2020. The return on the trade was 42.00%.
            What is Vuong Trieu's role in Sorrento Therapeutics?
            Vuong Trieu's role in Sorrento Therapeutics is CSO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.